New clinical features, opinion pieces and much more—outgoing Arthritis & Rheumatology Editor-in-Chief Daniel H. Solomon, MD, MPH, discusses how the journal has evolved and where it’s going.
Search results for: Primary care
Insights into ACR Open Rheumatology
ACR Open Rheumatology Editor-in-Chief Andras Perl, MD, PhD, discusses his unique career and his approach to balancing basic and translational research articles with outcome-focused articles within the journal.
Clinical Research & Practice with AC&R Editor-in-Chief Dr. Kelli Allen
Arthritis Care & Research (AC&R), a peer-reviewed journal published monthly, comprises original research, review articles and editorials that “move clinical research and practice forward in a meaningful way,” according to AC&R Editor-in-Chief Kelli D. Allen, PhD. That includes research on evidence-based practice; clinical problems; practice guidelines; educational, social, and public health issues; health economics and…
Cancer & RA Drugs: Are Some Drugs Riskier than Others?
Sendaydiego et al. asked: Do some DMARDs pose a greater cancer risk than others for patients with RA? Here are insights from the study and its clinical implications.
Reproductive Health, Biosimilars & More in Focus at SOTA 2025
Reproductive health, biosimilars, IgG4-related disease and much more—five speakers give us a sneak peek into important topics being addressed at the ACR’s 2025 State-of-the-Art Clinical Symposium, April 4–6.
Answering the Call: Anisha Dua, MD, MPH, Looks Ahead to New Role on Committee on Training
Building on her experiences in her practice and through the ACR, this rheumatology leader and educator is eager to advance the work of the COT.
Federally Funded Providers Must Provide Language Assistance Services by July 5
By July 5, all providers who participate in federally funded healthcare programs, including Medicare and Medicaid, must provide language assistance programs for patients to meet requirements of Section 1557 of the Affordable Care Act.
ARP Celebrates 58 Years of Achievements & Transformations, Identifies Challenges
ACR Convergence 2024—In a wide-ranging and engaging discussion, members of the Association of Rheumatology Professionals (ARP) tracked their progress over the years across clinical practice, research production and representation in the field, while outlining challenges and opportunities to come. The session at ACR Convergence included a panel and an audience full of past presidents of…
Retroperitoneal Fibrosis & IgG4-Related Disease
WASHINGTON, D.C.—Retroperitoneal fibrosis (RPF) is often a challenging diagnosis to make, given a lack of serologic biomarkers and often difficulty in accessing tissue for biopsy, especially in cases confined to the retroperitoneum. The topic of retroperitoneal fibrosis was discussed during the CARE to Test Your Knowledge: Retroperitoneal Fibrosis session at ACR Convergence 2024. John Stone,…
The Ethical Tug-of-War Over Biosimilar Adoption
The advent of biosimilar medications has offered the promise of significant cost savings for healthcare systems and patients. Biosimilars are highly similar versions of existing biologic drugs, providing a more affordable alternative once the original biologic patent expires. However, the adoption of biosimilars in the U.S. has been hampered by myriad roadblocks, many of which…
- « Previous Page
- 1
- …
- 64
- 65
- 66
- 67
- 68
- …
- 137
- Next Page »